209 related articles for article (PubMed ID: 11816170)
1. Recent advances in the understanding of HIV accessory protein function.
Steffens CM; Hope TJ
AIDS; 2001; 15 Suppl 5():S21-6. PubMed ID: 11816170
[No Abstract] [Full Text] [Related]
2. [Functional roles of HIV-1 accessory genes for its pathogenicity].
Adachi A; Kamada K; Hatcho K; Yamashita T; Uchiyama T; Nomaguchi M
Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1261-7. PubMed ID: 17824250
[No Abstract] [Full Text] [Related]
3. Molecular biology of the human immunodeficiency virus accessory proteins.
Subbramanian RA; Cohen EA
J Virol; 1994 Nov; 68(11):6831-5. PubMed ID: 7933064
[No Abstract] [Full Text] [Related]
4. HIV accessory proteins: multifunctional components of a complex system.
Bour S; Strebel K
Adv Pharmacol; 2000; 48():75-120. PubMed ID: 10987089
[No Abstract] [Full Text] [Related]
5. HIV accessory proteins: emerging therapeutic targets.
Miller RH; Sarver N
Mol Med; 1995 Jul; 1(5):479-85. PubMed ID: 8529114
[No Abstract] [Full Text] [Related]
6. HIV accessory proteins: leading roles for the supporting cast.
Trono D
Cell; 1995 Jul; 82(2):189-92. PubMed ID: 7628010
[No Abstract] [Full Text] [Related]
7. Inhibition of prokaryotic cell growth by HIV1 Vpr.
Bodéus M; Margottin F; Durand H; Rouer E; Benarous R
Res Virol; 1997; 148(3):207-13. PubMed ID: 9201811
[TBL] [Abstract][Full Text] [Related]
8. Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.
Rücker E; Grivel JC; Münch J; Kirchhoff F; Margolis L
J Virol; 2004 Nov; 78(22):12689-93. PubMed ID: 15507658
[TBL] [Abstract][Full Text] [Related]
9. Role of viral regulatory and accessory proteins in HIV-1 replication.
Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; Deng L; Dadgar S; Bottazzi ME; Ghedin E; Pumfery A; Kashanchi F
Front Biosci; 2004 Sep; 9():2388-413. PubMed ID: 15353294
[TBL] [Abstract][Full Text] [Related]
10. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.
Bour S; Strebel K
Microbes Infect; 2003 Sep; 5(11):1029-39. PubMed ID: 12941395
[TBL] [Abstract][Full Text] [Related]
11. Role of auxiliary proteins in retroviral morphogenesis.
Cohen EA; Subbramanian RA; Göttlinger HG
Curr Top Microbiol Immunol; 1996; 214():219-35. PubMed ID: 8791729
[No Abstract] [Full Text] [Related]
12. HIV accessory proteins as therapeutic targets.
Miller RH; Sarver N
Nat Med; 1997 Apr; 3(4):389-94. PubMed ID: 9095171
[No Abstract] [Full Text] [Related]
13. Regulation of HIV-1 gene expression.
Cullen BR
FASEB J; 1991 Jul; 5(10):2361-8. PubMed ID: 1712325
[TBL] [Abstract][Full Text] [Related]
14. Review of the twelfth West Coast Retrovirus Meeting.
Barry SM; Melar M; Gallay P; Hope TJ
Retrovirology; 2005 Nov; 2():72. PubMed ID: 16293194
[TBL] [Abstract][Full Text] [Related]
15. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
Aldrovandi GM; Zack JA
J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
[TBL] [Abstract][Full Text] [Related]
16. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
[TBL] [Abstract][Full Text] [Related]
17. Exchangeability of accessory Vif and Vpu proteins between various HIV/SIVs (review).
Adachi A; Iida S; Fukumori T; Tamaki M; Inubushi R; Shimano R; Oshima Y; Akari H; Koyama AH
Int J Mol Med; 1999 Feb; 3(2):193-7. PubMed ID: 9917529
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 accessory proteins--ensuring viral survival in a hostile environment.
Malim MH; Emerman M
Cell Host Microbe; 2008 Jun; 3(6):388-98. PubMed ID: 18541215
[TBL] [Abstract][Full Text] [Related]
19. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
20. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A
J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
